Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-tumour necrosis factor α therapy: results from the British Society for Rheumatology Biologics Register

BACKGROUND: Anti-tumour necrosis factor (TNF)α treatments improve outcome in severe rheumatoid arthritis (RA) and are efficacious in psoriasis and psoriatic arthritis. However recent case reports describe psoriasis occurring as an adverse event in patients with RA receiving anti-TNFα therapy. OBJECT...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Harrison, M J, Dixon, W G, Watson, K D, King, Y, Groves, R, Hyrich, K L, Symmons, D P M
Format: Artigo
Jezik:Inglês
Izdano: BMJ Publishing Group 2008
Teme:
Clinical and Epidemiological Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2605571/
https://ncbi.nlm.nih.gov/pubmed/18385277
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2007.087288
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki